{
  "meta": {
    "title": "00231_Late_Night_Pyqs_Mixed_Bag-52",
    "url": "https://brainandscalpel.vercel.app/00231-late-night-pyqs-mixed-bag-52-5cbce063.html",
    "scrapedAt": "2025-11-29T17:27:56.287Z"
  },
  "questions": [
    {
      "id": 54968,
      "choices": [
        {
          "id": 219333,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher's disease</span></p>"
        },
        {
          "id": 219334,
          "text": "<p><span style=\"font-size:12.0pt;\">Tay Sach's disease</span></p>"
        },
        {
          "id": 219335,
          "text": "<p><span style=\"font-size:12.0pt;\">Krabbe's disease</span></p>"
        },
        {
          "id": 219336,
          "text": "<p><span style=\"font-size:12.0pt;\">Fabry's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following lipid storage disorder presents with Cherry Red Spot in Macula? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q8472841",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588680,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tay Sach's disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tay Sachs disease is a lipid storage disorder that characteristically presents with a cherry-red spot in the macula. This appearance is due to the accumulation of gangliosides in the retinal ganglion cells, causing the macula to appear pale and contrasting with the normal red color of the fovea, creating the cherry-red spot appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gaucher's disease:</strong> While it may cause pseudo cherry-red spot and not a true cherry-red spot in ophthalmology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Krabbe's disease:</strong> This is a leukodystrophy that primarily affects the nervous system but does not typically cause a cherry-red spot in the macula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fabry's disease:</strong> While this condition can affect the eyes, it typically causes corneal verticillata (corneal whorls) rather than a cherry-red spot in the macula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cherry-red spot in the macula is a characteristic finding in several lipid storage disorders, with Tay Sachs disease being the most notable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>mnemonic \"BeE STING\"</strong> can be helpful in remembering causes of cherry-red spot: Berlin's Edema, Sclerosis, Tay-Sachs, Ischemia (CRAO), Niemann-Pick, and GM1 Gangliosidosis.</span></p>",
      "correct_choice_id": 219334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13067,
      "choices": [
        {
          "id": 52230,
          "text": "<p><span style=\"font-size:12.0pt;\">Durham's rule</span></p>"
        },
        {
          "id": 52231,
          "text": "<p><span style=\"font-size:12.0pt;\">Curren's rule</span></p>"
        },
        {
          "id": 52232,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        },
        {
          "id": 52233,
          "text": "<p><span style=\"font-size:12.0pt;\">Neither A nor B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following rules of law are associated with insanity? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q2704458",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588683,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Both A and B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Durham's rule and Curren's rule are laws associated with insanity.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Curren's rule of 1964 states that an accused person is not criminally responsible, if at the time of committing the act, he did not have the capacity to regulate his conduct to the requirements of the law, as a result of mental disease or defect.</span></li><li><span style=\"font-size:12.0pt;\">Durham 's rule of 1954 States that an accused person is not criminally responsible if his unlawful act is the product of mental disease or mental defect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both Durham's rule and Curren's rule are significant tests used to determine criminal responsibility in cases where the defendant's mental state is in question.</span></p>",
      "correct_choice_id": 52232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13693,
      "choices": [
        {
          "id": 54733,
          "text": "<p><span style=\"font-size:12.0pt;\">Attached to the inner border of 2nd rib</span></p>"
        },
        {
          "id": 54734,
          "text": "<p><span style=\"font-size:12.0pt;\">Covers apical part of lung</span></p>"
        },
        {
          "id": 54735,
          "text": "<p><span style=\"font-size:12.0pt;\">Attached with transverse process of C7</span></p>"
        },
        {
          "id": 54736,
          "text": "<p><span style=\"font-size:12.0pt;\">Vessels pass above the fascia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following statement is incorrect regarding Sibson’s fascia? (NEET PG 2018)</span></p>",
      "unique_key": "Q3729815",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588659,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Attached to the inner border of 2nd rib</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sibson's fascia is joined to the first rib's inner border, not the second rib.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sibson's fascia (suprapleural membrane)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Covers the apical portion of the lung and acts as a dividing line between the lower neck and the thorax.</span></li><li><span style=\"font-size:12.0pt;\">It is attached to the inner border of the 1st rib and posteriorly to the anterior border of the transverse process of the C7 vertebra.</span></li><li><span style=\"font-size:12.0pt;\">It is strengthened by a few spreading muscular fibers derived from the scalene muscles.</span></li><li><span style=\"font-size:12.0pt;\">The subclavian vessels lie on top of it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical significance</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The suprapleural membrane's function is to protect the apex of the lung (the part that extends outside the rib cage) and the cervical fascia. This aids in resisting intrathoracic pressure changes, preventing neck inflation and deflation during expiration and inspiration, and also providing rigidity to the thoracic inlet.</span></li><li><span style=\"font-size:12.0pt;\">Herniation of the cervical fascia may result due to injury to suprapleural membrane.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Covers apical part of lung (Correct)</strong>: Sibson's fascia covers the apical (uppermost) part of the lung and helps separate the cervical pleura from the surrounding structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Attached with transverse process of C7 (Correct): Sibson's fascia is posteriorly attached with the tip of the transverse process of C7.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Vessels pass above the fascia (Correct)</strong>: Blood vessels, including the subclavian vessels, pass above Sibson's fascia as they enter and exit the thoracic cavity. This fascia serves as a landmark for the placement of central venous catheters, as it delineates the boundary between the cervical and thoracic regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/image-100.jpg\" alt=\"\" width=\"500\" height=\"340\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Sibson's fascia is not directly attached to the inner border of the 2nd rib. Instead, it is associated with the cervical pleura and extends superiorly to attach to the transverse process of the 7th cervical (C7) vertebra. It forms the outer boundary of the cervicothoracic (suprapleural) space.</span></li></ul>",
      "correct_choice_id": 54733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55497,
      "choices": [
        {
          "id": 221445,
          "text": "<p><span style=\"font-size:12.0pt;\">Higher police official</span></p>"
        },
        {
          "id": 221446,
          "text": "<p><span style=\"font-size:12.0pt;\">Judicial magistrate</span></p>"
        },
        {
          "id": 221447,
          "text": "<p><span style=\"font-size:12.0pt;\">Medical examiner</span></p>"
        },
        {
          "id": 221448,
          "text": "<p><span style=\"font-size:12.0pt;\">Coroner</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Who conducts inquest in police custodial death? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q9757490",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588661,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Judicial magistrate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In India, an inquest can be conducted by either the police or a magistrate. A police inquest is the most common type of inquest. However, a magistrate inquest is conducted in specific cases. There are two types of magistrates who can conduct inquests: an executive magistrate and a judicial magistrate.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Executive Magistrate Inquest:&nbsp;</strong>This is performed in cases of <strong>dowry deaths and exhumation</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Judicial Magistrate Inquest:&nbsp;</strong>This is conducted in cases of <strong>custodial deaths</strong>, which can occur in various forms of custody such as police custody, prison, psychiatric hospitals, or rehabilitation homes where an under-trial accused might be placed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, in the event of a police custodial death, the inquest is conducted by a judicial magistrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Higher police official:</strong> While higher police officials may be involved in various administrative and investigative roles, they do not conduct inquests in cases of custodial deaths. The judicial magistrate is the designated authority for this purpose to ensure an unbiased investigation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Medical examiner:</strong> A medical examiner conducts autopsies and determines the cause of death, but does not conduct inquests. The role of the medical examiner is critical in providing medical evidence that supports the inquest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Coroner:</strong> The office of the coroner is not part of the Indian legal system. Instead, the role typically carried out by a coroner in other jurisdictions is fulfilled by magistrates in India.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In India, the inquest for a police custodial death is conducted by a judicial magistrate, ensuring an impartial investigation into the circumstances surrounding the death.</span></p>",
      "correct_choice_id": 221446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3015,
      "choices": [
        {
          "id": 12045,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta oxidation of branched chain fatty acid</span></p>"
        },
        {
          "id": 12046,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha oxidation of branched chain fatty acid</span></p>"
        },
        {
          "id": 12047,
          "text": "<p><span style=\"font-size:12.0pt;\">Omega oxidation of branched chain fatty acid</span></p>"
        },
        {
          "id": 12048,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha oxidation of dicarboxylic acids</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Refsum’s disease is caused by the defect of? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5803472",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588682,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Alpha oxidation of branched-chain fatty acid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Refsum's disease is a peroxisomal disorder caused by the impaired alpha-oxidation of branched-chain fatty acids, which results in the buildup of phytanic acid in the body. This accumulation of phytanic acid is a characteristic feature of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Beta oxidation of branched-chain fatty acid: </strong>Refsum's disease is not caused by the defect in beta oxidation of branched-chain fatty acids. Beta oxidation is a different metabolic process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Omega oxidation of branched-chain fatty acid: </strong>Refsum's disease is not caused by the defect in omega oxidation of branched-chain fatty acids. Omega oxidation is a different metabolic pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alpha oxidation of dicarboxylic acids: </strong>Refsum's disease primarily involves the defect in the alpha oxidation of branched-chain fatty acids, not the alpha oxidation of dicarboxylic acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Characteristic of Peroxisomal pathways:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">No ATP production in any of peroxisomal pathways</span></li><li><span style=\"font-size:12.0pt;\">H<sub>2</sub>O<sub>2 </sub>is regularly formed which is neutralized by peroxisomal enzymes catalase &amp; peroxidase.</span></li><li><span style=\"font-size:12.0pt;\">Two pathways which occur in peroxisomes are:</span></li></ul><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">1. α-Oxidation of branched chain fatty acids (BCFA)</span></p><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">2. Oxidation of Very Long Chain Fatty Acid (VLCFA)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Refsum's disease:&nbsp;</strong>Occur due to defect in α-oxidation of BCFA in peroxisomes due to defect in phytanic acid hydroxylase. So, Phytanic acid not oxidised.</span></p><ul><li><span style=\"font-size:12.0pt;\">Beta-oxidation occurs for saturated and even chain fatty acids like palmitic and stearic acid</span></li><li><span style=\"font-size:12.0pt;\">In Omega-oxidation dicarboxylic acids are formed. In MCAD deficiency there is dicarboxylic acidosis and non-ketotic hypoglycemia.</span></li></ul>",
      "correct_choice_id": 12046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8823,
      "choices": [
        {
          "id": 35259,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B fibers are more susceptible to pressure than A fibers</span></span></span></p>"
        },
        {
          "id": 35260,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A fibers are more sensitive to pressure than C fibers</span></span></span></p>"
        },
        {
          "id": 35261,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C fibers are more sensitive to pressure than A fibers</span></span></span></p>"
        },
        {
          "id": 35262,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Motor nerves are more affected by sleep than sensory nerves</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A man falls into a deep sleep with one arm under his head. He finds he is not able to move this arm when he awakens. However, it tingles and pain sensation in the arm is still intact. What is the reason for the loss of motor function without loss of pain sensation is that in the nerves to his arm?(NEET PG 2020)</span></span></p>",
      "unique_key": "Q6445462",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588696,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. A fibers are more sensitive to pressure than C fibers</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation &nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The reason for the loss of motor function without loss of pain sensation is that in the nerves to his arm, A-fibers are more sensitive to pressure than C fibers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/690.jpg\" style=\"height:665px; width:740px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pressure on a nerve due to sleeping with arms under the head leads to the loss of conduction in large-diameter motor, touch, and pressure fibers, while pain sensation remains relatively intact.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. B fibers are more susceptible to pressure than A fibers</span></strong><span style=\"font-size:12.0pt\">: Incorrect. B fibers, which are generally involved in autonomic functions, are not the primary concern in this scenario involving motor and sensory disturbances.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. C fibers are more sensitive to pressure than A fibers</span></strong><span style=\"font-size:12.0pt\">: Incorrect. It&#39;s the opposite; A fibers are more sensitive to pressure than C fibers, making them more likely to be compromised under mechanical compression.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Motor nerves are more affected by sleep than sensory nerves</span></strong><span style=\"font-size:12.0pt\">: Incorrect. The loss of function is not due to sleep per se but due to mechanical pressure affecting nerve conduction.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In situations where pressure is applied to nerves, such as sleeping with an arm in a compromising position, the larger, myelinated A fibers (including motor fibers) are more susceptible to disruption compared to the smaller, unmyelinated C fibers. This leads to a loss of motor function and normal touch sensation, while pain sensation remains relatively intact due to the resilience of C fibers to mechanical pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Relative susceptibility of nerve fibres &ndash; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-120424.png\" style=\"height:240px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "correct_choice_id": 35260,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10230,
      "choices": [
        {
          "id": 40886,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 12 months</span></p>"
        },
        {
          "id": 40887,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 12 months</span></p>"
        },
        {
          "id": 40888,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 6 months</span></p>"
        },
        {
          "id": 40889,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 35-year-old patient presents to the outpatient department with a satellite skin lesion. On examination, the patient has one hypopigmented lesion and one thickened nerve. The images of two blister packs are provided. Based on the WHO / NLEP Guidelines, which treatment is most appropriate for this patient?</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture2_e7rPz6c.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p>",
      "unique_key": "Q8554025",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<h3><span style=\"color:#1F3763;font-size:10.5pt;\">Answer:</span></h3><p><span style=\"font-size:10.5pt;\">The correct answer is <strong>B. Packet 2 for 12 months</strong>.</span></p><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p>&nbsp;</p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:494.25pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>World health organization (WHO)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\">No&nbsp;</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\">≥1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><span style=\"font-size:10.5pt;\"><i>*If a case has any one of the three features suggestive of MB, he/she is classified as MB.</i></span></p><p>&nbsp;</p><p><span style=\"font-size:13.5pt;\"><strong>Treatment Regimen: WHO &amp; NLEP (Post April 1st 2025)</strong></span></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TAhJtvE.png\" alt=\"A chart of medication\r\n\r\n\r\n\r\n\r\n\r\nDescription automatically generated with medium confidence\" width=\"337\" height=\"172\"></span></p><figure class=\"image\"><img style=\"aspect-ratio:184/239;\" src=\"https://tnhealth.tn.gov.in/tngovin/dph/images/mbadultdose.png\" alt=\"Health &amp; Family Welfare Department, Government of Tamil Nadu\" width=\"184\" height=\"239\"></figure><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QuOAkXI.png\" width=\"463\" height=\"250\"></span></p><p>&nbsp;</p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Other Options:</span></h3><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option A: Packet 1 for 12 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option C: Packet 1 for 6 months:&nbsp;</strong></span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option D Packet 2 for 6 months:</strong>&nbsp;</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">Although Packet 2 contains the correct medications, the treatment duration of 6 months is insufficient for multibacillary leprosy according to WHO guidelines, which recommends 12 months.</span></p><p>&nbsp;</p><p><strong>OLD NLEP GUIDELINES to diagnose Leprosy&nbsp;</strong></p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:469.5pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>National Leprosy Eradication Programme (NLEP)&nbsp;</strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary&nbsp;</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary&nbsp;</strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">1-5&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\">No or 1 nerve</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\">&gt;1&nbsp;</span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">Absent&nbsp;</span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">Present&nbsp;</span></td></tr></tbody></table></figure><p><strong>OLD NLEP GUIDELINES to treat Leprosy&nbsp;</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cv8eRBC.png\" alt=\"A chart of drugs and drugs\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"243\"></p><p><strong>OLD PB MDT with 2 drugs followed by NLEP:</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F3OLXAd.png\" alt=\"A green label with black circles and white text\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"257\"></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><i><strong>Educational objective:</strong></i></span></p><ul><li>As of <strong>April 1, 2025</strong>, <strong>NLEP follows WHO guidelines</strong> for both <strong>diagnosis and treatment</strong>.</li><li>Classification is based on <strong>skin lesions</strong>, <strong>nerve involvement</strong>, and <strong>skin smear</strong>.</li><li><span style=\"font-size:10.5pt;\">For a patient with <i><strong>multibacillary leprosy</strong></i>, characterized by <i><strong>one or more thickened nerves</strong></i> and <i><strong>multiple skin lesions</strong></i>, the appropriate treatment is with a regimen containing <i><strong>rifampicin, clofazimine, and dapsone (Packet 2)</strong></i> for a duration of <i><strong>12 months.</strong></i></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Jopling’s handbook of leprosy, 6<sup>th</sup> edition, page no 10</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Andrew’s diseases of the skin: clinical dermatology 13<sup>th</sup> edition page no 338, 339, 345</strong></span></p>",
      "correct_choice_id": 40887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5944,
      "choices": [
        {
          "id": 23746,
          "text": "<p><span style=\"font-size:12pt;\">Stop antibiotics and start heparin</span></p>"
        },
        {
          "id": 23747,
          "text": "<p><span style=\"font-size:12pt;\">Antibiotics + Heparin</span></p>"
        },
        {
          "id": 23748,
          "text": "<p><span style=\"font-size:12pt;\">Surgical embolectomy</span></p>"
        },
        {
          "id": 23749,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old pregnant lady presents with fever and is put on antibiotics. Fever is still not brought under control. On further investigation, she is diagnosed to have septic pelvic thrombophlebitis. Which among the following is the next course of treatment for her? (NEET PG 2019)</span></p>",
      "unique_key": "Q5328071",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588687,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Antibiotics + Heparin</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Antibiotics + heparin:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Septic pelvic thrombophlebitis (SPT) is a rare postpartum infective complication characterized by persistent high-grade fever despite broad-spectrum antibiotic therapy. It typically occurs after delivery or abortion and is often seen in women with risk factors like cesarean section, prolonged labor, or pelvic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The fever in SPT is caused by a septic thrombus in the pelvic veins—most commonly the ovarian vein—that harbors bacteria and incites a sustained inflammatory response. Since antibiotics alone cannot fully penetrate the infected thrombus, the addition of anticoagulation (usually low molecular weight heparin) is essential. Heparin helps in lysing the thrombus, preventing further propagation and improving antibiotic penetration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical improvement is usually seen within 48–72 hours of initiating combined therapy with antibiotics and heparin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stop antibiotics and start heparin</strong>:&nbsp; Incorrect because infection is still present—antibiotics are needed to control the infective component. &nbsp;Stopping antibiotics would worsen sepsis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Surgical embolectomy:&nbsp;</strong>&nbsp;Too invasive and not first-line. &nbsp;Reserved for rare cases with septic emboli or failure to respond to medical management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hysterectomy:&nbsp;</strong>Not indicated unless there’s uncontrolled pelvic infection not responding to medical therapy or associated endomyometritis with uterine necrosis.&nbsp; SPT is usually confined to pelvic veins, not requiring removal of the uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The best management for pregnant women with antiphospholipid syndrome (APS) to prevent recurrent pregnancy loss includes low-dose aspirin and low molecular weight heparin (LMWH).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2951, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54978,
      "choices": [
        {
          "id": 219373,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac Sprue</span></span></span></p>"
        },
        {
          "id": 219374,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ulcerative Colitis</span></span></span></p>"
        },
        {
          "id": 219375,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Whipple&#39;s disease</span></span></span></p>"
        },
        {
          "id": 219376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Crohn&#39;s disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatitis Herpetiformis as a skin manifestation is seen in cases of? </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q4661392",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588676,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Celiac Sprue</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatitis herpetiformis is a chronic skin condition characterized by intensely itchy blisters and raised red patches. It is strongly associated with Celiac disease, also known as Celiac sprue or gluten-sensitive enteropathy. This autoimmune disorder is triggered by the ingestion of gluten, leading to damage in the small intestine and associated skin manifestations like dermatitis herpetiformis. The presence of IgA antibodies against transglutaminase in both the gut and the skin is a key feature linking these conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Options B. Ulcerative Colitis&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">and&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Crohn&#39;s disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an inflammatory bowel disease that primarily affects the colon and rectum. It is not associated with dermatitis herpetiformis but can be linked to other skin manifestations like pyoderma gangrenosum and erythema nodosum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythema Nodosum&nbsp;</span></strong><span style=\"font-size:12.0pt\">is c</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">haracterized by tender red nodules, typically appearing on the shins, and frequently associated with IB</span><span style=\"font-size:12.0pt\">D</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Whipple&#39;s disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a rare bacterial infection that affects multiple systems in the body, including the gastrointestinal tract. It does not have an association with dermatitis herpetiformis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermatitis herpetiformis&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is a specific skin manifestation associated with <strong>Celiac disease</strong> and should prompt the evaluation for gluten sensitivity </span><span style=\"font-size:12.0pt\">enteropathy </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">in affected patients.</span></span></span></p>",
      "correct_choice_id": 219373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56035,
      "choices": [
        {
          "id": 223569,
          "text": "<p><span style=\"font-size:12pt;\">Herpes zoster</span></p>"
        },
        {
          "id": 223570,
          "text": "<p><span style=\"font-size:12pt;\">Herpes genitalis</span></p>"
        },
        {
          "id": 223571,
          "text": "<p><span style=\"font-size:12pt;\">Warts</span></p>"
        },
        {
          "id": 223572,
          "text": "<p><span style=\"font-size:12pt;\">Chancroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A male present with grouped painful vesicular lesions in the genital area. History of multiple sexual partners present. Irregular use of condoms history present. Smear showed MNGCs. What is the diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-104909.png\" alt=\"\" width=\"400\" height=\"330\"></p><p>&nbsp;</p>",
      "unique_key": "Q5434325",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588681,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans</strong>. <strong>B) Herpes genitalis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Herpes genitalis is a sexually transmitted infection caused by the herpes simplex virus (HSV). The presentation of grouped painful vesicular lesions on an erythematous base in the genital area, especially in a patient with a history of multiple sexual partners and irregular condom use, is highly suggestive of herpes genitalis. The presence of multinucleated giant cells (MNGCs) on a smear is a key diagnostic feature of HSV infection. This is because HSV causes the fusion of infected cells, leading to the formation of these giant cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Herpes zoster:&nbsp;</strong>Herpes zoster (shingles) typically presents as painful vesicular lesions following a <strong>dermatomal distribution, usually on one side of the body</strong>. The lesions do not cluster in the genital area unless the sacral nerve is involved, which is uncommon. Also, the absence of a dermatomal pattern makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Warts:&nbsp;</strong>Genital warts, caused by human papillomavirus (HPV), present as painless, cauliflower-like growths rather than painful vesicular lesions. The description of painful lesions and the presence of MNGCs on the smear make this option unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Chancroid:&nbsp;</strong>Chancroid, caused by Haemophilus ducreyi, presents as a painful genital ulcer with ragged edges and undermined borders. It does not present with vesicular lesions or MNGCs on a smear, making this diagnosis incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Herpes genitalis should be considered when a patient presents with grouped painful vesicular lesions in the genital area, especially when there is a history of risky sexual behavior and multinucleated giant cells are observed on a smear.</span></p>",
      "correct_choice_id": 223570,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57609,
      "choices": [
        {
          "id": 229805,
          "text": "<p><span style=\"font-size:18px;\">Monthly IFA supplementations</span></p>"
        },
        {
          "id": 229806,
          "text": "<p><span style=\"font-size:18px;\">Sanitary napkins distribution</span></p>"
        },
        {
          "id": 229807,
          "text": "<p><span style=\"font-size:18px;\">Albendazole for deworming</span></p>"
        },
        {
          "id": 229808,
          "text": "<p><span style=\"font-size:18px;\">Health check-ups</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following is not a component of School Health under Ayushman Bharat Program? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q3711075",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588695,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Monthly IFA supplementations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Ayushman Bharat Program includes a comprehensive school health component aimed at improving the health and hygiene of school children. The key components include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Weekly Iron Folic Acid Supplementation (WIFS):</strong> This involves the distribution of iron and folic acid supplements on a weekly basis to prevent anemia among school children. Monthly supplementation is not part of this program; hence, \"Monthly IFA supplementations\" is the incorrect option.</span></li><li><span style=\"font-size:18px;\"><strong>Sanitary Napkins Distribution:</strong> Under the menstrual hygiene scheme, sanitary napkins branded as \"Freedays\" are distributed to adolescent girls to promote menstrual hygiene.</span></li><li><span style=\"font-size:18px;\"><strong>Albendazole for Deworming:</strong> Deworming through albendazole is conducted to reduce the prevalence of intestinal worm infestations among school-aged children.</span></li><li><span style=\"font-size:18px;\"><strong>Health Check-ups:</strong> Regular health screenings are conducted to assess the physical and mental fitness of students, ensuring early identification and management of health issues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Ayushman Bharat School Health Program includes weekly IFA supplementation, not monthly, along with other health initiatives like menstrual hygiene, deworming, screening health check-ups, physical &amp; mental fitness, Research and Vaccination</span></p>",
      "correct_choice_id": 229805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1029,
      "choices": [
        {
          "id": 4112,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">6 weeks</span></p>"
        },
        {
          "id": 4113,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">8-10 weeks</span></p>"
        },
        {
          "id": 4114,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">12 weeks</span></p>"
        },
        {
          "id": 4115,
          "text": "<p><span style=\"font-size:12pt;\">4 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">How long should elective surgery be deferred for a patient who had cough and fever, after he has recovered from COVID-19, and has not required any hospitalization?</span></p>",
      "unique_key": "Q7762113",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588693,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) 6 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Elective surgery deferral based on respiratory disease severity and COVID-19 recovery:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>4 weeks:</strong> For an asymptomatic patient with mild respiratory symptoms.</span></li><li><span style=\"font-size:12pt;\"><strong>6 weeks:</strong> For a symptomatic patient who did not need hospital treatment.</span></li><li><span style=\"font-size:12pt;\"><strong>8 weeks:</strong> For a symptomatic patient who was hospitalized in the ward.</span></li><li><span style=\"font-size:12pt;\"><strong>12 weeks:</strong> For a patient who was admitted to the intensive care unit due to respiratory infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Application:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">As this patient was symptomatic but did not need hospitalization, elective surgery can be deferred for 6 weeks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 8-10 weeks: </strong>This timeline is recommended for symptomatic patients who were hospitalized in the ward, which does not apply to this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 12 weeks: </strong>This timeline is for patients who were admitted to the intensive care unit due to a respiratory infection, which also does not apply to this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 4 weeks: </strong>This timeline is for asymptomatic patients with mild respiratory symptoms, which is not the case for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Elective surgery should be deferred for 6 weeks in a patient who had cough and fever due to COVID-19 but did not require hospitalization. This ensures sufficient recovery time to reduce perioperative risks.</span></li></ul><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong> <strong>2423</strong></span></p>",
      "correct_choice_id": 4112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5501,
      "choices": [
        {
          "id": 21976,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        },
        {
          "id": 21977,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
        },
        {
          "id": 21978,
          "text": "<p><span style=\"font-size:12.0pt;\">British anti Lewisite</span></p>"
        },
        {
          "id": 21979,
          "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 5-year-old child has taken 10 iron tablets and presents with nausea and abdominal pain. What should be given to the child? (Fmge Jan 2023)</span></p>",
      "unique_key": "Q5817565",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588658,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Desferrioxamine.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Desferrioxamine is an antidote of iron toxicity. It is an intravenous iron-chelating compound. It can be safely administered in children. It is drug of choice for acute iron poisoning.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Deferipirone is oral iron chelator and is drug of choice for chronic iron poisoning.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Penicillamine</strong>: It is a copper chelating agent. It is used in Wilson’s disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Dimercaprol or British Anti Lewisite or BAL</strong>: Is used in heavy metal poisonings like mercury, arsenic, lead.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. EDTA</strong>: Is a chelating agent which is used as an antidote for lead poisoning.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In cases of acute iron poisoning, particularly in children, Desferrioxamine is the appropriate treatment. It is an intravenous iron-chelating agent that binds free iron, facilitating its excretion and mitigating the toxic effects of the overdose. Other chelating agents like penicillamine, BAL, and EDTA are used for different types of heavy metal poisonings and are not suitable for treating iron toxicity.</span></p>",
      "correct_choice_id": 21976,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47628,
      "choices": [
        {
          "id": 190123,
          "text": "<p><span style=\"font-size:12.0pt;\">&lt; 6.0</span></p>"
        },
        {
          "id": 190124,
          "text": "<p><span style=\"font-size:12.0pt;\">&lt; 6.5</span></p>"
        },
        {
          "id": 190125,
          "text": "<p><span style=\"font-size:12.0pt;\">&lt; 7.0</span></p>"
        },
        {
          "id": 190126,
          "text": "<p><span style=\"font-size:12.0pt;\">&lt; 7.5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old patient with long-standing type 2 diabetes came to the OPD with complaints of fatigue and frequent urination. His FBS = 144 mg/dl &amp; PPBS = 210 mg/dl. What is the target HbA1c for adequate control of diabetes? (</span>FMGE Jan 2024)</p>",
      "unique_key": "Q1940481",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588689,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) &lt; 7.0</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The universal target HbA1c for adequate control of diabetes is generally less than 7%. This target helps in reducing the risk of diabetic complications. However, it is important to consider individual patient factors when setting targets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In very old and frail patients, a less stringent target of less than 8% may be appropriate to avoid the risks of hypoglycemia and other complications. Since the options do not include 8%, the standard target of less than 7% is selected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The target HbA1c for most patients with diabetes to ensure adequate control is less than 7%, though this may vary based on individual patient circumstances.</span></p>",
      "correct_choice_id": 190125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24847,
      "choices": [
        {
          "id": 99349,
          "text": "<p><span style=\"font-size:12.0pt;\">Concha bullosa</span></p>"
        },
        {
          "id": 99350,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumatised superior turbinate</span></p>"
        },
        {
          "id": 99351,
          "text": "<p><span style=\"font-size:12.0pt;\">Onodi cell</span></p>"
        },
        {
          "id": 99352,
          "text": "<p><span style=\"font-size:12.0pt;\">Haller cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the marked structure in the given CT image. (INICET NOVEMBER 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-094423.png\" alt=\"\" width=\"400\" height=\"301\"></p>",
      "unique_key": "Q9956506",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pneumatised superior turbinate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The&nbsp;superior turbinates&nbsp;form one of the three pairs of&nbsp;conchae&nbsp;in the&nbsp;nose&nbsp;and represent part of the&nbsp;labyrinth of the ethmoid bone, arising as bony projections from its posterior surface.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The air passage between the superior nasal concha and the lateral nasal wall is known as the&nbsp;superior meatus&nbsp;and forms part of the&nbsp;nasal cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Concha bullosa</strong> is a pneumatized middle turbinate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture48.jpg\" alt=\"\" width=\"300\" height=\"257\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Onodi cell</strong>/ Sphenoethmoidal air cell is the posterior most&nbsp;ethmoidal air cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture49.jpg\" alt=\"\" width=\"300\" height=\"328\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haller cell/</strong> infraorbital ethmoidal air cells are ethmoid air cells located lateral to the maxillo-ethmoidal suture along the inferomedial orbital floor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/picture50.jpg\" alt=\"\" width=\"300\" height=\"226\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pneumatisation of the superior turbinate, indicates the presence of air spaces within the turbinates, which can have implications for nasal physiology and potential sinus pathologies.</span></p>",
      "correct_choice_id": 99350,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6033,
      "choices": [
        {
          "id": 24102,
          "text": "<p><span style=\"font-size:12pt;\">Elemental calcium of 1200mg/ day is recommended</span></p>"
        },
        {
          "id": 24103,
          "text": "<p><span style=\"font-size:12pt;\">Oral vit D3 is to be given with calcium</span></p>"
        },
        {
          "id": 24104,
          "text": "<p><span style=\"font-size:12pt;\">Teriparatide is to be started first if treatment with teriparatide and bisphosphonates is being considered</span></p>"
        },
        {
          "id": 24105,
          "text": "<p><span style=\"font-size:12pt;\">Bisphosphonates should not be given for more than 1 year</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year post-menopausal obese lady presents with backache. She has a history of Colle’s fracture 1 year back. A DEXA scan shows a T score of less than - 2.5. Which of the following is false?</span>&nbsp;(NEET PG 2021)</p>",
      "unique_key": "Q7807160",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588677,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Bisphosphonates should not be given for more than 1 year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Management of Osteoporosis:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Elemental Calcium and Vitamin D:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Postmenopausal women are recommended to take 1200 mg/day of elemental calcium along with 400-800 IU of vitamin D to help maintain bone health and reduce the risk of fractures.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Bisphosphonates:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Bisphosphonates such as Alendronate, Risedronate, Ibandronate, and Zoledronic acid are commonly used to treat osteoporosis. These drugs help to slow down bone resorption, thus preserving bone density.</span></li><li><span style=\"font-size:12pt;\">The recommended duration of bisphosphonate therapy is generally 3-5 years, not limited to just 1 year. Studies have shown that longer-term use of bisphosphonates can continue to provide benefits in reducing the risk of fractures. However, the exact duration should be individualized based on the patient's risk factors and response to treatment.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Teriparatide:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Teriparatide is a recombinant form of parathyroid hormone that stimulates new bone formation. It is particularly beneficial in patients with severe osteoporosis or those who have not responded well to bisphosphonates.</span></li><li><span style=\"font-size:12pt;\"><strong>When considering treatment with both teriparatide and bisphosphonates, it is often recommended to start with teriparatide first to build bone and then follow with bisphosphonates to maintain the bone density gains achieved with teriparatide.</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Elemental calcium of 1200mg/day is recommended:&nbsp;</strong>This statement is true. Adequate calcium intake is essential for bone health, especially in postmenopausal women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Oral vit D3 is to be given with calcium:&nbsp;</strong>This statement is true. Vitamin D3 helps in the absorption of calcium and is recommended to be given along with calcium supplements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Teriparatide is to be started first if treatment with teriparatide and bisphosphonates is being considered:&nbsp;</strong>This statement is true. Starting with teriparatide helps build bone density, and following with bisphosphonates helps maintain the gains.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bisphosphonates should not be given for more than 1 year:&nbsp;</strong>This statement is false. Bisphosphonates can be given for a longer duration, typically 3-5 years, depending on the patient's individual risk factors and response to therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Bisphosphonates are typically recommended for a duration of 3-5 years in the treatment of osteoporosis, not limited to just 1 year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 500, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 24105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11214,
      "choices": [
        {
          "id": 44822,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral loss of joint sense and position</span></span></span></span></p>"
        },
        {
          "id": 44823,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral loss of pain sensation</span></span></span></span></p>"
        },
        {
          "id": 44824,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral loss of complete sensory functions</span></span></span></span></p>"
        },
        {
          "id": 44825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral motor functions </span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is the characteristic pattern seen in Brown-Sequard syndrome? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q4428191",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588691,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Contralateral loss of pain sensation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brown Sequard syndrome is produced due to <strong>lateral hemi-section of spinal cord</strong>. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features include:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral weakness +</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral loss of joint position and vibratory sense +</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral loss of pain &amp; temperature sense one or two levels below lesion +</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral segmental signs like radicular pain, muscle atrophy, or loss of tendon reflex</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Contralateral loss of joint sense and position:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, as joint sense and position loss occur ipsilaterally due to dorsal column damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ipsilateral loss of complete sensory functions:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, sensory loss is not complete and is dissociated; pain and temperature sensations are lost contralaterally while proprioception and vibration are lost ipsilaterally.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Contralateral motor functions:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, motor function loss (weakness or paralysis) occurs ipsilaterally below the level of the lesion.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Brown-Sequard syndrome, the characteristic neurological pattern includes ipsilateral motor weakness and proprioceptive loss, alongside contralateral loss of pain and temperature sensation, due to a lateral hemisection of the spinal cord.</span></span></span></span></p>",
      "correct_choice_id": 44823,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6044,
      "choices": [
        {
          "id": 24146,
          "text": "<p><span style=\"font-size:12pt;\">Not age specific</span></p>"
        },
        {
          "id": 24147,
          "text": "<p><span style=\"font-size:12pt;\">35-55 years</span></p>"
        },
        {
          "id": 24148,
          "text": "<p><span style=\"font-size:12pt;\">55-85 years</span></p>"
        },
        {
          "id": 24149,
          "text": "<p><span style=\"font-size:12pt;\">Both of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the age group distribution for vulval cancer?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6748919",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588667,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 55-85 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>55-85 years:</strong> Correct. The majority of vulval cancer cases are diagnosed in women aged 55 to 85 years. The average age of diagnosis is between 60 and 65 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Vulval cancer primarily affects older women, and its age distribution is as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Not age specific:</strong> Incorrect. Vulval cancer is not \"not age specific\"; it is specifically associated with an older age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. 35-55 years:</strong> Incorrect. Although vulval cancer can occur in younger women, the majority of cases are diagnosed in the older age group, typically between 55 and 85 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Both of the above:</strong> Incorrect. The age distribution for vulval cancer does not cover both age groups mentioned (35-55 years and 55-85 years) equally. The more accurate distribution is predominantly in the 55-85 years range.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Vulval cancer predominantly affects women aged 55 to 85 years, with the average diagnosis occurring between 60 and 65 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 333, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57589,
      "choices": [
        {
          "id": 229725,
          "text": "<p><span style=\"font-size:18px;\">Nitrate test</span></p>"
        },
        {
          "id": 229726,
          "text": "<p><span style=\"font-size:18px;\">Phosphatase test</span></p>"
        },
        {
          "id": 229727,
          "text": "<p><span style=\"font-size:18px;\">Paper chromatography test</span></p>"
        },
        {
          "id": 229728,
          "text": "<p><span style=\"font-size:18px;\">Sulphuric acid test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A lot of patients presented to PHC OPD with edema, ocular problems, cardiac failure. Several deaths were reported too. There was a common history of buying oil from a local grocery store. Drug inspector will use the following test to detect adulteration. </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q2663215",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588679,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Paper chromatography test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The condition described in the question is <strong>epidemic dropsy</strong>, which is caused by the consumption of <strong>mustard oil adulterated with Argemone Mexicana oil.</strong> The toxic component of Argemone oil is <strong>Sanguinarine</strong>, a potent toxin that inhibits the oxidation of pyruvic acid, leading to symptoms such as <strong>bilateral non-inflammatory edema, glaucoma, congestive heart failure, and even death.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Paper chromatography test</strong> is the most sensitive method to detect Argemone oil adulteration in mustard oil, even at extremely low concentrations (0.0001%). This test identifies the presence of Sanguinarine, thus confirming the contamination of the mustard oil with Argemone oil.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Other test is - Nitric acid test shows an orange-brown discoloration if Argemone oil is present, requiring a concentration of 0.25% for a positive result.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Nitrate test: </strong>This option is incorrect. The nitrate test is commonly employed to detect nitrates in water, food, or soil.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Phosphatase test:&nbsp; </strong>This option is incorrect. The phosphatase test is used primarily to determine the pasteurization status of milk, not for detecting oil adulteration.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Sulphuric acid test: </strong>This option is incorrect. While sulphuric acid can be used in various tests, it is not the specific test for detecting Argemone oil adulteration in mustard oil.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Epidemic dropsy is caused by the consumption of mustard oil adulterated with Argemone Mexicana oil, and the most sensitive test for detecting this adulteration is the paper chromatography test.</span></p>",
      "correct_choice_id": 229727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4247,
      "choices": [
        {
          "id": 16965,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rocky mountain spotted fever</span></span></span></p>"
        },
        {
          "id": 16966,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malaria</span></span></span></p>"
        },
        {
          "id": 16967,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">COVID-19</span></span></span></p>"
        },
        {
          "id": 16968,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scrub typhus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which disease causes the lesion shown in the image below?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture5_y6cRShi.jpg\" style=\"height:216px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9594707",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588662,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Scrub typhus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The lesion shown in the image is eschar. It is seen in scrub typhus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scrub typhus</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is an infectious disease caused by the rickettsial bacterium Orientia tsutsugamushi.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is transmitted to humans by the bite of the <strong>larva of trombiculid mites</strong>. Later it causes disseminated vasculitis and perivascular inflammation ultimately leading to significant vascular leakage leading to end-organ injury.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features usually arise after an incubation period of 6-21 days and manifest as fever, headache, myalgia, and gastrointestinal symptoms. An eschar which usually begins as a primary papular lesion later crusts to form a <strong>black ulcer with central necrosis</strong> is a distinct feature of scrub typhus although its presence varies in different regions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A classic case of&nbsp;</span></span></span><strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">Rocky mountain spotted fever (RMSF)</span><span style=\"font-style:normal\">&nbsp;</span></span></strong><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">involves a rash that appears 2-4 days after the onset of fever as small, flat, pink, macules on the wrists, forearms, and ankles and spreads to include the trunk and sometimes the <strong>palms of hands and soles of feet</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B:</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Malaria</strong> is a protozoal disease caused by Plasmodium species characterized by periodic bouts of fever with chills and rigors, followed by anemia, splenomegaly, and hepatomegaly.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D: COVID-19</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scrub typhus, caused by Orientia tsutsugamushi, is characterized by an eschar at the site of the mite bite, along with fever and systemic symptoms.</span></span></span></p>",
      "correct_choice_id": 16968,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47539,
      "choices": [
        {
          "id": 189767,
          "text": "<p><span style=\"font-size:12.0pt;\">S</span></p>"
        },
        {
          "id": 189768,
          "text": "<p><span style=\"font-size:12.0pt;\">G2M</span></p>"
        },
        {
          "id": 189769,
          "text": "<p><span style=\"font-size:12.0pt;\">M</span></p>"
        },
        {
          "id": 189770,
          "text": "<p><span style=\"font-size:12.0pt;\">G1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most radiosensitive phase of a cell cycle?&nbsp;</span>(FMGE JANUARY 2024)</p>",
      "unique_key": "Q7608474",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588678,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) G2M</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cell cycle consists of several phases, including the quiescent phase (G0), G1 phase, S phase, G2 phase, and M phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The G2/M phase of the cell cycle is the most radiosensitive. This phase is critical for cell division, involving DNA repair mechanisms and the process of mitosis. Radiosensitivity is heightened due to the cells’ high mitotic activity and the presence of condensed chromosomes, which are more susceptible to damage by radiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. S phase:</strong> Cells are synthesizing DNA and are somewhat resistant to radiation because DNA repair enzymes are active. S phase is the most radioresistant phase of the cell cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. M phase:</strong> Although mitosis is a rapid process, its radiosensitivity is slightly less than G2/M phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. G1 phase:</strong> This phase involves the growth and preparation of the cell for DNA synthesis; cells in G1 are less sensitive to radiation compared to G2/M.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note – Phases of cell cycle –</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/21/screenshot-2024-06-21-113700_bZscd6n.png\" alt=\"\" width=\"500\" height=\"352\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/21/screenshot-2024-06-21-113747_Kkl1BM5.png\" alt=\"\" width=\"1000\" height=\"227\"></p>",
      "correct_choice_id": 189768,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54842,
      "choices": [
        {
          "id": 218829,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B, C are correct</span></p>"
        },
        {
          "id": 218830,
          "text": "<p><span style=\"font-size:12.0pt;\">B &amp; C are correct</span></p>"
        },
        {
          "id": 218831,
          "text": "<p><span style=\"font-size:12.0pt;\">B, C &amp;&nbsp; D are correct</span></p>"
        },
        {
          "id": 218832,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these are included in extra-esophageal symptoms of GERD? (multiple correct combinations) (INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Asthma</span><br><span style=\"font-size:12.0pt;\">b. Laryngitis</span><br><span style=\"font-size:12.0pt;\">c. Excessive phlegm</span><br><span style=\"font-size:12.0pt;\">d. Pulmonary fibrosis</span></p>",
      "unique_key": "Q1310953",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588665,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gastroesophageal reflux disease (GERD) is typically associated with symptoms such as heartburn, epigastric pain, and acid reflux. However, GERD can also present with a variety of extra-esophageal symptoms, which are manifestations outside the esophagus. These symptoms arise due to the aspiration of gastric contents or the stimulation of vagal reflexes.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Asthma:</strong> Nocturnal asthma can be triggered or exacerbated by GERD due to the reflux of stomach acid that can reach the airways, leading to bronchoconstriction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Laryngitis:</strong> Laryngitis can occur when acid reflux irritates the laryngeal mucosa, leading to hoarseness or loss of voice.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Excessive phlegm:</strong> GERD can lead to chronic throat clearing and excessive phlegm production as the body attempts to clear the irritating reflux material from the throat.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pulmonary fibrosis:</strong> Although less common, repeated aspiration of gastric contents can cause chronic inflammation in the lungs, leading to pulmonary fibrosis over time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Since the &nbsp;includes all options, there are no incorrect choices to explain in this instance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GERD can manifest not only with typical esophageal symptoms like heartburn but also with extra-esophageal symptoms such as asthma, laryngitis, excessive phlegm, and even pulmonary fibrosis.</span></p>",
      "correct_choice_id": 218832,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56095,
      "choices": [
        {
          "id": 223805,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        },
        {
          "id": 223806,
          "text": "<p><span style=\"font-size:12.0pt;\">Fomepizole</span></p>"
        },
        {
          "id": 223807,
          "text": "<p><span style=\"font-size:12.0pt;\">Naltrexone</span></p>"
        },
        {
          "id": 223808,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which drug would be most effective in preventing withdrawal symptoms in a patient with a history of alcohol consumption who was admitted to the hospital after a road traffic accident? (NEET PG 2024)</span></p>",
      "unique_key": "Q5069211",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588690,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a benzodiazepine commonly used to manage alcohol withdrawal symptoms. Alcohol withdrawal can present with symptoms like anxiety, tremors, seizures, and delirium tremens, which can be life-threatening. Benzodiazepines, such as lorazepam, work by enhancing the effect of the neurotransmitter GABA, which has a calming effect on the nervous system, thereby reducing the risk of withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fomepizole</strong>: This drug is an alcohol dehydrogenase inhibitor used primarily in the <strong>treatment of methanol and ethylene glycol poisoning</strong>, not for managing alcohol withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Naltrexone</strong>: Naltrexone is an opioid receptor antagonist used to reduce cravings and <strong>prevent relapse in patients recovering from alcohol or opioid dependence</strong>. It is not used to manage acute withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Buspirone</strong>: Buspirone is an anxiolytic used for the <strong>management of generalized anxiety disorder (GAD</strong>). It is not effective for treating alcohol withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Benzodiazepines, such as lorazepam, are the drugs of choice to prevent and manage alcohol withdrawal symptoms.</span></p>",
      "correct_choice_id": 223805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6777,
      "choices": [
        {
          "id": 27077,
          "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
        },
        {
          "id": 27078,
          "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-A, 3-B, 4-C</span></p>"
        },
        {
          "id": 27079,
          "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 27080,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-C, 3-D, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the given cellular components with their respective marker enzymes?&nbsp;</span>&nbsp;(INICET MAY 2022)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-121517.png\" alt=\"\" width=\"1000\" height=\"242\"></p><p>&nbsp;</p>",
      "unique_key": "Q9184003",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588660,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;1-D, 2-A, 3-B, 4-C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct matches of cellular components with their marker enzymes are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Mitochondria - ATP synthase (D):&nbsp;</strong>ATP synthase is a key enzyme in the mitochondria involved in the synthesis of ATP, making it a marker enzyme for this organelle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Peroxisomes - Catalase (A):&nbsp;</strong>Catalase is an enzyme found in peroxisomes that helps in the breakdown of hydrogen peroxide, making it a characteristic marker for peroxisomes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Golgi complex - Galactosyl transferase (B):&nbsp;</strong>Galactosyl transferase is involved in the glycosylation processes in the Golgi complex, serving as a marker enzyme for this organelle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Endoplasmic reticulum - Glucose-6-phosphatase (C):&nbsp;</strong>Glucose-6-phosphatase is found in the endoplasmic reticulum and is involved in glucose metabolism, making it a marker enzyme for this structure.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-121810.png\" alt=\"\" width=\"1000\" height=\"766\"></strong></span></p>",
      "correct_choice_id": 27078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57125,
      "choices": [
        {
          "id": 227889,
          "text": "<p><span style=\"font-size:12.0pt;\">Coccidioides immitis</span></p>"
        },
        {
          "id": 227890,
          "text": "<p><span style=\"font-size:12.0pt;\">Histoplasmosis</span></p>"
        },
        {
          "id": 227891,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucormycosis</span></p>"
        },
        {
          "id": 227892,
          "text": "<p><span style=\"font-size:12.0pt;\">Paracoccidioidomycosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Desert rheumatism is caused by: (NEET PG 2024)</span></p>",
      "unique_key": "Q4546736",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588694,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Coccidioides immitis</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Desert rheumatism, also known as Valley fever or California fever, is caused by the fungus Coccidioides immitis. This fungus is commonly found in desert regions, such as the southwestern United States, including California and Arizona. The disease is contracted by inhaling airborne fungal spores, which can cause symptoms ranging from mild flu-like conditions to severe pulmonary or disseminated infections. The mnemonic \"Desert, Valley, Cali\" helps remember the association with desert rheumatism, Valley fever, and California fever, all linked to Coccidioides immitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Histoplasmosis:</strong> This condition is caused by the fungus Histoplasma capsulatum, which is commonly found in bird and bat droppings, particularly in the Ohio and Mississippi River valleys. It does not cause desert rheumatism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mucormycosis:</strong> This is an infection caused by molds from the Mucorales order, which typically affects immunocompromised individuals. It is not associated with desert rheumatism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Paracoccidioidomycosis:</strong> This disease is caused by the fungus Paracoccidioides brasiliensis and occurs predominantly in South America. It is unrelated to desert rheumatism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Desert rheumatism (Valley fever or California fever) is caused by the fungus Coccidioides immitis.</span></p>",
      "correct_choice_id": 227889,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57125/Neet_Pg_Aug_2024_Microbiology_Q_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57125/Neet_Pg_Aug_2024_Microbiology_Q_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55478,
      "choices": [
        {
          "id": 221369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incidence will decrease &amp; prevalence will increase.</span></span></span></p>"
        },
        {
          "id": 221370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incidence will increase &amp; prevalence will decrease.</span></span></span></p>"
        },
        {
          "id": 221371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incidence &amp; prevalence of a disease are not related to it.</span></span></span></p>"
        },
        {
          "id": 221372,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incidence will increase &amp; prevalence will increase because the prevalence is related to incidence.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Morbidity of a disease is increasing. Identify the correct statement. (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q5856838",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588684,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Incidence will increase &amp; prevalence will increase because the prevalence is related to incidence.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Morbidity refers to the presence of disease within a population and is characterized by two key parameters: <strong>incidence</strong> and <strong>prevalence</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Incidence</span></strong><span style=\"font-size:12.0pt\"> refers to the number of new cases of a disease occurring in a specified population during a certain period. It is a rate, typically expressed per 1000 individuals.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prevalence</span></strong><span style=\"font-size:12.0pt\"> refers to the total number of cases (both new and existing) of a disease in a population at a given time. It is a proportion, expressed as a percentage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The mathematical relationship between incidence and prevalence is given by the formula:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prevalence = Incidence &times; Mean&nbsp;Duration&nbsp;of&nbsp;Disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When morbidity of a disease is increasing, it indicates that the number of new cases (incidence) is rising. This increase in incidence will subsequently lead to an increase in prevalence since more individuals in the population will have the disease over time. Unless there is a significant change in the duration of the disease, both incidence and prevalence will rise together.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When the morbidity of a disease increases, both the incidence and prevalence of the disease are likely to increase, as they are interrelated. Prevalence depends on the incidence rate and the duration of the disease.</span></span></span></p>",
      "correct_choice_id": 221372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47647,
      "choices": [
        {
          "id": 190199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Translocation</span></span></span></span></p>"
        },
        {
          "id": 190200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inversion</span></span></span></span></p>"
        },
        {
          "id": 190201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deletion</span></span></span></span></p>"
        },
        {
          "id": 190202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insertion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male presents with features of massive splenomegaly. On examination, his TLC was more than 85,000/mm&sup3; with immature cells and a shift to the left with the presence of the Philadelphia chromosome. The mutation associated with the Philadelphia chromosome is? (</span></span>FMGE Jan 2024)</p>",
      "unique_key": "Q6361441",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588663,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Translocation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Myeloid Leukemia (CML) is characterized by the presence of the Philadelphia chromosome, which results from a <strong>balanced reciprocal translocation</strong> between <strong>chromosomes 9 and 22</strong>. Specifically, the ABL1 gene on chromosome 9 is translocated to the BCR gene on chromosome 22, resulting in the <strong>BCR-ABL fusion gene</strong>. This fusion gene encodes a protein with constitutively active tyrosine kinase activity, which leads to uncontrolled cell proliferation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Inversion</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This involves a segment of a chromosome being reversed end to end. It is not associated with the formation of the Philadelphia chromosome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Deletion</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This refers to the loss of a chromosome segment. It is not related to the Philadelphia chromosome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Insertion</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This involves the addition of one or more nucleotide base pairs into a DNA sequence. It is not the mechanism behind the Philadelphia chromosome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Philadelphia chromosome is the result of a balanced reciprocal translocation between chromosomes 9 and 22, forming the BCR-ABL fusion gene, which is a <strong>hallmark of Chronic Myeloid Leukemia (CML).</strong></span></span></span></span></p>",
      "correct_choice_id": 190199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57092,
      "choices": [
        {
          "id": 227757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A secondary oocyte arrested in Meiosis 1</span></span></span></p>"
        },
        {
          "id": 227758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A primary oocyte arrested in Meiosis 1</span></span></span></p>"
        },
        {
          "id": 227759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A primary oocyte arrested in Meiosis 2</span></span></span></p>"
        },
        {
          "id": 227760,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A secondary oocyte arrested in Meiosis 2</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In oogenesis, after ovulation, the egg is? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q5602935",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588674,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) A secondary oocyte arrested in Meiosis 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oogenesis is the process by which the female gametes, or ova, are produced. This process begins in fetal life, where the primary oocytes are formed and arrested in the diplotene phase of Meiosis 1. These primary oocytes remain arrested until puberty, at which point they complete Meiosis 1 to form a secondary oocyte and a polar body, both of which are haploid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After ovulation, the secondary oocyte enters Meiosis 2 but does not complete it; instead, it becomes arrested in Metaphase 2. This secondary oocyte remains arrested until fertilization. If fertilization occurs, Meiosis 2 is completed, resulting in the formation of a mature ovum. If fertilization does not occur, the secondary oocyte remains arrested in Meiosis 2 and is eventually discarded.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. A secondary oocyte arrested in Meiosis 1:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect because the secondary oocyte arrests in Meiosis 2, not Meiosis 1. The arrest in Meiosis 1 applies to the primary oocyte during fetal development until puberty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. A primary oocyte arrested in Meiosis 1:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect because the primary oocyte is arrested in Meiosis 1 until puberty, not after ovulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. A primary oocyte arrested in Meiosis 2:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect because the primary oocyte does not enter Meiosis 2. Only the secondary oocyte enters and arrests in Meiosis 2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After ovulation, the egg is a secondary oocyte that is arrested in Meiosis 2 and will only complete this division if fertilization occurs.</span></span></span></p>",
      "correct_choice_id": 227760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1288,
      "choices": [
        {
          "id": 5147,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Dilated loops of intestine with valvulae conniventes</span></p>"
        },
        {
          "id": 5148,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">String of pearls sign</span></p>"
        },
        {
          "id": 5149,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Central dilated bowel loops</span></p>"
        },
        {
          "id": 5150,
          "text": "<p><span style=\"font-size:12.0pt;\">Dilated loops with haustrations</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is a finding of large bowel obstruction? (INICET NOV 2020)</span></p>",
      "unique_key": "Q8099351",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588664,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Dilated loops with haustrations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dilated bowel loops with haustrations is a feature of large bowel obstruction.</span></p><p><span style=\"font-size:12.0pt;\">Large bowel obstructions have colonic distension proximal to the obstruction with the distal portion collapsed. The colon is considered dilated if it is more than 6 cm in diameter while the cut off for caecum is 9cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dilated loops of intestine with valvulae conniventes:</strong> Dilated loops of the intestine with plica circulars (valvulae conniventes) and predominantly central loops are features of the small bowel obstruction. The small bowel is considered dilated if it is more than 3 cm in diameter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. String of pearls sign:</strong> The string of pearls sign is also a feature of small bowel obstruction seen in plain radiographs or CT. It represents a row of gas bubbles trapped between the valvulae conniventes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Central dilated bowel loops:</strong> While central dilation can occur in any intestinal obstruction, it is more typical of small bowel obstruction where the loops tend to centrally accumulate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Identifying dilated loops with haustrations is critical for diagnosing large bowel obstruction, helping differentiate it from small bowel obstruction, which features dilated loops with valvulae conniventes and may show the string of pearls sign.</span></p>",
      "correct_choice_id": 5150,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14595,
      "choices": [
        {
          "id": 58341,
          "text": "<p><span style=\"font-size:12.0pt;\">Pelviureteric junction obstruction</span></p>"
        },
        {
          "id": 58342,
          "text": "<p><span style=\"font-size:12.0pt;\">Putty kidney</span></p>"
        },
        {
          "id": 58343,
          "text": "<p><span style=\"font-size:12.0pt;\">Staghorn calculus</span></p>"
        },
        {
          "id": 58344,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic kidney</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 28-year-old female presented to the urologist with complaints of abdominal pain and recurrent urinary tract infections. Upon examination, the physician noted tenderness in the lower abdomen and a palpable mass in the right flank area. Further evaluation revealed the following. What is the likely diagnosis?&nbsp; (NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/07/ns21.jpg\" alt=\"\" width=\"258\" height=\"194\"></span></p>",
      "unique_key": "Q9456246",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588671,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Pelviureteric junction obstruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The clinical scenario and the imaging indicate a likely diagnosis of pelviureteric junction (PUJ) obstruction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pelviureteric junction obstruction is a condition where there is a blockage at the point where the renal pelvis meets the ureter.</span></li><li><span style=\"font-size:12pt;\">This blockage can lead to hydronephrosis, which is the swelling of a kidney due to a buildup of urine.</span></li><li><span style=\"font-size:12pt;\">PUJ obstruction can be congenital (present at birth) or acquired. Symptoms can include flank pain, recurrent UTIs, and a palpable mass in severe cases.</span></li><li><span style=\"font-size:12pt;\">The findings from imaging studies, showing hydronephrosis (dilated pelvicalyceal system), would support this diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Putty kidney:</strong> A putty kidney refers to a kidney that has been extensively damaged by tuberculosis. The kidney appears pale, and is often shrunk, firm, and non-functional. It would not typically cause a palpable mass and recurrent UTIs in the described manner of the patient in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Staghorn calculus:</strong> Staghorn calculi are large kidney stones that occupy a large portion of the renal pelvis and its calyces, often having a shape resembling a stag's horn. They can lead to recurrent UTIs and can sometimes be palpable, especially if the kidney is also enlarged due to obstruction. However, the description in the question and the image seems more indicative of an obstruction at the PUJ rather than a staghorn calculus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Cystic kidney:</strong> A cystic kidney, as the name suggests, is characterized by multiple cysts in the kidney. There are several diseases, like polycystic kidney disease, that can lead to cyst formation in kidneys. These cysts can sometimes cause pain, enlarged kidneys, and in some cases, recurrent UTIs. However, the specific findings from the imaging study mentioned in the question don't necessarily align with a simple cystic kidney diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the findings mentioned in the question, a palpable mass in the right flank area, tenderness in the lower abdomen, and imaging results, Pelviureteric junction obstruction (Option A) is the most consistent and likely diagnosis for the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pelviureteric junction obstruction is a condition causing blockage where the renal pelvis meets the ureter, leading to hydronephrosis and symptoms like flank pain and recurrent UTIs.</span></li><li><span style=\"font-size:12pt;\">Imaging typically shows a dilated pelvicalyceal system.</span></li></ul>",
      "correct_choice_id": 58341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6520,
      "choices": [
        {
          "id": 26049,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-10</span></p>"
        },
        {
          "id": 26050,
          "text": "<p><span style=\"font-size:12.0pt;\">Histone deacetylase</span></p>"
        },
        {
          "id": 26051,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine A1</span></p>"
        },
        {
          "id": 26052,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta 2 adrenergic receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Theophylline was prescribed to a male patient with chronic obstructive pulmonary disease (COPD). The next day, he noticed that his urine output had increased. Which of the following receptors is responsible for the drug's action?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q5381441",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588673,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine A1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline is a methylxanthine drug that primarily acts as a nonselective adenosine receptor antagonist. By antagonizing adenosine A1 receptors, theophylline can lead to diuresis or increased urine output. Adenosine normally promotes water reabsorption in the renal tubules, and its blockade by theophylline results in increased urine production. This mechanism is separate from its therapeutic action in COPD, which involves bronchodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Interleukin-10</strong>: Interleukin-10 (IL-10) is an anti-inflammatory cytokine. It is not a direct target of theophylline. IL-10 plays a role in regulating immune responses, but it is not involved in the diuretic effect or the primary action of theophylline in COPD treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Histone Deacetylase</strong>: Histone deacetylase (HDAC) is an enzyme involved in chromatin remodelling and gene expression regulation. While theophylline has been suggested to have some modulatory effects on HDAC, especially in the context of COPD and asthma, it is not the mechanism responsible for the increased urine output observed in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Beta 2 Adrenergic Receptors</strong>: While theophylline has mild bronchodilatory effects thought to be mediated through inhibition of phosphodiesterase (increasing cAMP levels in smooth muscle), leading to relaxation of bronchial smooth muscles, beta 2 adrenergic receptors are more specifically targeted by drugs like salbutamol. Theophylline's diuretic effect is not mediated through beta 2 adrenergic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline increases urine output by antagonizing adenosine A1 receptors, leading to decreased water reabsorption in the renal tubules and resulting in diuresis.</span></p>",
      "correct_choice_id": 26051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11353,
      "choices": [
        {
          "id": 45378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antiarrhythmics</span></span></span></p>"
        },
        {
          "id": 45379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV NaHCO3</span></span></span></p>"
        },
        {
          "id": 45380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propranolol</span></span></span></p>"
        },
        {
          "id": 45381,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phenytoin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient on antidepressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q1539203",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. IV NaHCO3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with symptoms indicative of tricyclic antidepressant (TCA) overdose, which includes hypotension, wide QRS complexes, and right axis deviation on the ECG. TCAs can block sodium channels in the heart, leading to QRS widening and the potential for serious arrhythmias. They also have anticholinergic effects, which can contribute to the clinical picture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first-line treatment for TCA overdose, especially in the presence of cardiac toxicity such as wide QRS complexes, is intravenous sodium bicarbonate (IV NaHCO3). Sodium bicarbonate works by alkalinizing the blood, which helps to overcome the sodium channel blockade caused by TCAs. It also increases the extracellular sodium concentration, which can help stabilize cardiac cell membranes and improve conduction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Antiarrhythmics</strong>: While antiarrhythmics might be considered in other cases of cardiac arrhythmias, they are not the first-line treatment for TCA overdose. In fact, some antiarrhythmic drugs can worsen the condition by further blocking sodium channels or prolonging the QT interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Propranolol</strong>: Propranolol is a beta-blocker used to treat high blood pressure and certain types of arrhythmias. However, it is not indicated for the treatment of TCA toxicity and can potentially exacerbate hypotension and cardiac conduction abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Phenytoin</strong>: Phenytoin is an anticonvulsant that can also be used for certain types of arrhythmias. However, it is not effective in treating the sodium channel blockade caused by TCAs and is not recommended for managing TCA overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary treatment for tricyclic antidepressant overdose, especially when presenting with wide QRS complexes and right axis deviation, is intravenous sodium bicarbonate (IV NaHCO3).</span></span></p>",
      "correct_choice_id": 45379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55754,
      "choices": [
        {
          "id": 222449,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase</span></p>"
        },
        {
          "id": 222450,
          "text": "<p><span style=\"font-size:12.0pt;\">GALT enzyme</span></p>"
        },
        {
          "id": 222451,
          "text": "<p><span style=\"font-size:12.0pt;\">Pompe disease</span></p>"
        },
        {
          "id": 222452,
          "text": "<p><span style=\"font-size:12.0pt;\">Niemann-Pick disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presented with intellectual disability and hepatosplenomegaly. Bone marrow biopsy showed a “crumpled paper appearance.” What is your best diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180526.jpeg\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
      "unique_key": "Q4934773",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588669,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) Glucocerebrosidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>Ans.</strong> is Glucocerebrosidase, which is associated with Gaucher disease. Gaucher disease is a lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase. This deficiency leads to the accumulation of glucocerebroside within macrophages, resulting in cells that have a characteristic \"crumpled paper\" appearance when viewed under a microscope. The presence of these cells, along with symptoms like intellectual disability and hepatosplenomegaly, strongly suggests Gaucher disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. GALT enzyme:</strong> This enzyme is related to Galactosemia, a disorder of galactose metabolism. It does not present with a \"crumpled paper appearance\" in bone marrow biopsies, nor is it associated with the symptoms described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pompe disease:</strong> Pompe disease is a glycogen storage disorder due to a deficiency of the enzyme acid alpha-glucosidase. It typically involves muscle weakness and cardiomegaly but does not produce the \"crumpled paper\" cells seen in bone marrow biopsies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Niemann-Pick disease:</strong> This is another lysosomal storage disorder, but it is due to sphingomyelinase deficiency. The characteristic cells in Niemann-Pick disease have a \"foamy\" appearance, not the \"crumpled paper\" appearance seen in Gaucher disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"crumpled paper appearance\" in bone marrow cells is a hallmark of Gaucher disease, caused by a deficiency of the enzyme glucocerebrosidase.</span></p>",
      "correct_choice_id": 222449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31814,
      "choices": [
        {
          "id": 127126,
          "text": "<p><span style=\"font-size:12pt;\">Folinic acid</span></p>"
        },
        {
          "id": 127127,
          "text": "<p><span style=\"font-size:12pt;\">Flumazenil</span></p>"
        },
        {
          "id": 127128,
          "text": "<p><span style=\"font-size:12pt;\">Naloxone</span></p>"
        },
        {
          "id": 127129,
          "text": "<p><span style=\"font-size:12pt;\">Fomepizole</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following drugs is used for the treatment of benzodiazepine overdose? (Fmge July 2023)</span></p>",
      "unique_key": "Q4485710",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588672,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Flumazenil</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Flumazenil is the drug used for treating benzodiazepine overdose. It acts as a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor, effectively reversing the sedative effects of benzodiazepines.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Folinic acid:</strong> Folinic acid is used to reduce the toxicity of methotrexate and as an antidote for folic acid antagonists, not for benzodiazepine overdose.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Naloxone:</strong> Naloxone is an opioid antagonist used to treat opioid overdose, not benzodiazepine overdose.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Fomepizole:</strong> Fomepizole is an antidote used for methanol or ethylene glycol poisoning, not for benzodiazepine overdose.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Flumazenil is used for the treatment of benzodiazepine overdose due to its action as a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor, effectively reversing sedative effects.</span></p>",
      "correct_choice_id": 127127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9939,
      "choices": [
        {
          "id": 39722,
          "text": "<p><span style=\"font-size:12.0pt;\">Tubulo-villous adenoma</span></p>"
        },
        {
          "id": 39723,
          "text": "<p><span style=\"font-size:12.0pt;\">Hamartomatous polyp</span></p>"
        },
        {
          "id": 39724,
          "text": "<p><span style=\"font-size:12.0pt;\">Villous Adenoma</span></p>"
        },
        {
          "id": 39725,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperplastic polyp</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy was diagnosed with intussusception and is taken up for surgery. The surgeon found multiple polyps and sent the resected section for histopathology. The image is given below. What is the type of lesion?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/13.jpg\" alt=\"\" width=\"300\" height=\"237\"></span></p>",
      "unique_key": "Q9860277",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588697,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>B) Hamartomatous polyp</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image and clinical scenario point towards a <strong>hamartomatous polyp</strong>, particularly because of the patient's young age and the finding of multiple polyps. Hamartomatous polyps are generally solitary lesions but can be multiple in certain syndromes, such as <strong>Peutz-Jeghers syndrome</strong> and <strong>juvenile polyposis syndrome</strong>, which are more common in children and adolescents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hamartomatous polyps are benign, disorganized growths of tissue that are normally found in the location where they arise. In the context of Peutz-Jeghers syndrome, these polyps are associated with an increased risk of intussusception due to their size and location in the gastrointestinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tubulo-villous adenoma</strong>: This type of adenoma has both tubular and villous features and is typically found in older adults, with a higher risk of malignant transformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Villous Adenoma</strong>: These are the most dangerous types of adenomas due to their higher potential for malignancy, but they are usually seen in older patients and have a distinctive villous histological appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperplastic polyp</strong>: Generally benign and more common in adults, hyperplastic polyps are typically located in the distal colon and rectum and are not associated with intussusception or multiple polyps in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-181904.jpg\" alt=\"\" width=\"1000\" height=\"769\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans pathologic basis of disease 8th edition pg 1557</strong></span></p>",
      "correct_choice_id": 39723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13920,
      "choices": [
        {
          "id": 55641,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Pinguecula</span></p>"
        },
        {
          "id": 55642,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Concretions</span></p>"
        },
        {
          "id": 55643,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Pterygium</span></p>"
        },
        {
          "id": 55644,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Bitots spots</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely diagnosis from the image given below?&nbsp;(NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-123.jpg\" alt=\"\" width=\"300\" height=\"266\"></span></p>",
      "unique_key": "Q5689627",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588670,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Pterygium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The likely diagnosis, based on the above image, is pterygium.</span></p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is a subconjunctival fibrovascular tissue encroaching the cornea.</span></li><li><span style=\"font-size:12.0pt;\">It is a wing-shaped fold of conjunctiva encroaching upon the cornea from either side within the interpalpebral fissure.</span></li><li><span style=\"font-size:12.0pt;\">It is more common in people living in hot climates, and a response to prolonged effect of environmental factors such as exposure to sun (ultraviolet rays), dry heat, high wind and abundance of dust.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">It is more common in elderly males doing outdoor work.</span></li><li><span style=\"font-size:12.0pt;\">It may be unilateral or bilateral.</span></li><li><span style=\"font-size:12.0pt;\">It presents as a triangular fold of conjunctiva encroaching the cornea in the area of palpebral aperture, usually on the nasal side but may also occur on the temporal side.</span></li><li><span style=\"font-size:12.0pt;\">Deposition of iron seen sometimes in corneal epithelium anterior to advancing head of pterygium is called stocker's line.</span></li><li><span style=\"font-size:12.0pt;\">Mostly <strong>asymptomatic</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Irritation</strong> <strong>and</strong> <strong>grittiness</strong> are caused by a dellen – localized drying of tear film.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cosmesis</strong> may be a significant problem.</span></li><li><span style=\"font-size:12.0pt;\">Visual disturbances occur when it encroaches the pupillary area or due to corneal <strong>astigmatism</strong> induced due to fibrosis in the regressive stage.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diplopia</strong> may occur due to limitation of ocular movements.</span></li><li><span style=\"font-size:12.0pt;\"><strong>PARTS OF A PTERYGIUM:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A fully developed pterygium consists of three parts</span></p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">Head (apical part present on the cornea),</span></li><li><span style=\"font-size:12.0pt;\">Neck (limbal part), and</span></li><li><span style=\"font-size:12.0pt;\">Body (scleral part) extending between limbus and the canthus.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Differences between pterygium and pseudopterygium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-150720.png\" alt=\"\" width=\"1000\" height=\"502\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-163108.png\" alt=\"\" width=\"1000\" height=\"642\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pinguecula:</strong> A yellowish, benign growth on the conjunctiva that does not encroach onto the cornea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Concretions:</strong> Small, yellowish-white deposits on the conjunctiva, often associated with chronic conjunctivitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bitot's spots:</strong> Foamy, whitish lesions on the conjunctiva, typically associated with vitamin A deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pterygium is characterized by a wing-shaped fold of conjunctiva encroaching upon the cornea, commonly seen in people exposed to prolonged environmental factors like UV rays and dust. The treatment includes surgical removal and techniques to prevent recurrence.</span></p>",
      "correct_choice_id": 55643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2876,
      "choices": [
        {
          "id": 11489,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxidative decarboxylation of alpha-ketoglutarate is increased.</span></p>"
        },
        {
          "id": 11490,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Increased synthesis of glutamine and glutamate from alpha-ketoglutarate</span></p>"
        },
        {
          "id": 11491,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased ATP synthesis</span></p>"
        },
        {
          "id": 11492,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperammonaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false in a patient with advanced liver disease?</span></p>",
      "unique_key": "Q1088180",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588668,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Oxidative decarboxylation of alpha-ketoglutarate</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>“Oxidative decarboxylation of alpha-ketoglutarate</strong> is increased is false.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This process occurs in the <strong>TCA (Krebs)</strong> <strong>cycle </strong>and is catalyzed by <strong>alpha-ketoglutarate dehydrogenase</strong>, a mitochondrial enzyme.</span></p><p><br><span style=\"font-size:12.0pt;\">In <strong>advanced liver disease, alpha-ketoglutarate is diverted toward glutamate and glutamine synthesis </strong>(to help detoxify ammonia), which decreases its availability for the TCA cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increased synthesis of glutamine and glutamate from alpha-ketoglutarate</strong> is true. In liver disease, there is an increased synthesis of glutamine and glutamate as a way to detoxify ammonia.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Decreased ATP synthesis</strong> is true. in advanced liver disease, ammonia levels increase which withdraws α-ketoglutarate to form glutamate and glutamine. This in turn results in lowered concentrations of citric acid cycle intermediates, and hence decreased ATP synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperammonemia</strong> is true. In advanced liver disease, the liver's ability to detoxify ammonia is compromised, leading to elevated ammonia levels in the bloodstream, resulting in hyperammonemia.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Detoxification of ammonia takes place in the liver, where it is metabolised and excreted as urea (urea cycle). Due to impairment of ammonia metabolism in advanced liver disease, ammonia levels increase which withdraws α-ketoglutarate to form glutamate and glutamine.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/8_P1vZFTO.jpg\" alt=\"\" width=\"600\" height=\"187\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This in turn results in lowered concentrations of citric acid cycle intermediates, and hence decreased ATP synthesis.</span></p>",
      "correct_choice_id": 11489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31873,
      "choices": [
        {
          "id": 127362,
          "text": "<p><span style=\"font-size:12pt;\">8 mg</span></p>"
        },
        {
          "id": 127363,
          "text": "<p><span style=\"font-size:12pt;\">15 mg</span></p>"
        },
        {
          "id": 127364,
          "text": "<p><span style=\"font-size:12pt;\">20 mg</span></p>"
        },
        {
          "id": 127365,
          "text": "<p><span style=\"font-size:12pt;\">40 mg</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 70-year-old male arrives at the emergency department with symptoms indicative of an acute ischemic stroke. It is decided to administer recombinant tissue plasminogen activator (rtPA), with a total dose of 80 mg. How much should be given as the initial bolus dose? (FMGE July 2023)</span></p>",
      "unique_key": "Q4842214",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588685,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) 8 mg</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">For the administration of recombinant tissue plasminogen activator (rtPA) in acute ischemic stroke, the initial bolus dose should be 10% of the total dose. Therefore, for a total dose of 80 mg, the initial bolus dose should be 8 mg (which is 10% of 80 mg).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">When administering rtPA for acute ischemic stroke, the initial bolus dose should be 10% of the total dose. For an 80 mg total dose, the initial bolus is 8 mg, followed by an infusion of the remaining dose over 60 minutes.</span></p>",
      "correct_choice_id": 127362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20345,
      "choices": [
        {
          "id": 81341,
          "text": "<p><span style=\"font-size:18px;\">Repeat sputum smears</span></p>"
        },
        {
          "id": 81342,
          "text": "<p><span style=\"font-size:18px;\">Ask for CBNAAT</span></p>"
        },
        {
          "id": 81343,
          "text": "<p><span style=\"font-size:18px;\">Ask for line probe assay</span></p>"
        },
        {
          "id": 81344,
          "text": "<p><span style=\"font-size:18px;\">Wait until TB culture results to start ATT</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A 35-year-old homeless man presented with a 1-month history of fever, cough, and weight loss. Both sputum smears turned out to be negative, but the chest x-ray ordered was suggestive of tuberculosis. According to the recent NTEP guidelines, which is the next best line of management? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
      "unique_key": "Q2340360",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588692,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Ask for CBNAAT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">According to the National Tuberculosis Elimination Programme (NTEP) guidelines, the next step in managing a patient with a high clinical suspicion of tuberculosis (TB), a suggestive chest x-ray, and negative sputum smears is to perform a CBNAAT (Cartridge-Based Nucleic Acid Amplification Test). CBNAAT is a molecular test that detects the DNA of Mycobacterium tuberculosis and can also identify rifampicin resistance, providing rapid and accurate results.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>DIAGNOSTIC TESTS UNDER NTEP:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">1. Sputum smear Microscopy</span></p><ul><li><span style=\"font-size:18px;\">ZN staining</span></li><li><span style=\"font-size:18px;\">LED – FM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">2. Culture</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">LJ Medium</span></li><li><span style=\"font-size:18px;\">Automated Liquid culture (ALC)</span><ul><li><span style=\"font-size:18px;\">&nbsp;BACTEC MGIT 960</span></li><li><span style=\"font-size:18px;\">BACTALERT</span></li><li><span style=\"font-size:18px;\">VERSATREK</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">3. Drug sensitivity testing</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Moderate Proportionate Sensitivity testing PST MGiT 960</span></li><li><span style=\"font-size:18px;\">Economic proportionate sensitivity testing 1% LJ Medium</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">4. Molecular Diagnosis test:</span></p><ul><li><span style=\"font-size:18px;\">Line Probe Assay</span><ul><li><span style=\"font-size:18px;\">LPA TB</span></li><li><span style=\"font-size:18px;\">PL LPA– INH &amp; Rifampicin Resistance</span></li><li><span style=\"font-size:18px;\">SL LPA-FQ / SLI Resistance</span></li><li><span style=\"font-size:18px;\">NAAT</span></li><li><span style=\"font-size:18px;\">CBNAAT</span></li><li><span style=\"font-size:18px;\">True NAT True NAT</span></li></ul></li><li><span style=\"font-size:18px;\">Developed by ICMR Real time PCR Technology&nbsp;</span><ul><li><span style=\"font-size:18px;\">True NAT MTB- MTB</span></li><li><span style=\"font-size:18px;\">True NAT MTB plus- MTB</span></li><li><span style=\"font-size:18px;\">True NAT MTB Dx- Rifampicin Resistance TEP:</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Repeat sputum smears:&nbsp;</strong>Is not appropriate since the patient already had two negative sputum smears and a chest x-ray suggestive of tuberculosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. CBNAAT:&nbsp;</strong>Should be performed first than Line probe assay.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. TB:&nbsp;</strong>Culture takes time to yield results, the patient may deteriorate in the meantime.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/01/whatsapp-image-2023-06-12-at-190121022.jpg\" alt=\"\" width=\"700\" height=\"426\"></strong></span></p>",
      "correct_choice_id": 81342,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10028,
      "choices": [
        {
          "id": 40078,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia of chronic disorder</span></p>"
        },
        {
          "id": 40079,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 40080,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron-deficiency anemia</span></p>"
        },
        {
          "id": 40081,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy was brought to OPD with complaint of fatigue. Serum investigations revealed findings as given below. What is the likely diagnosis? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemoglobin – 9 g/dl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mean cell volume (MCV) – 60 fL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mean cell Hb (MCH) – 20 pg</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serum Ferritin – 185 mcg/L</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total leukocyte count – Elevated lymphocyte and Neutrophils</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">[Reference normal values for this question: Serum Ferritin: 50-200 mcg/L; Mean cell volume (MCV) - 80-100 fL; Mean cell Hb (MCH) - 27-31 pg]</span></p>",
      "unique_key": "Q6952071",
      "question_audio": null,
      "question_video": null,
      "map_id": 22588675,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thalassemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of fatigue, along with laboratory findings, strongly suggests <strong>thalassemia</strong>.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>MCV of 60 fL&nbsp;</strong>and <strong>MCH of 20 pg</strong> are both very low, indicating microcytic hypochromic anemia, which is typical in thalassemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Serum ferritin</strong> is within the normal range (185 mcg/L), which rules out iron-deficiency anemia, as that condition would typically present with low ferritin levels.</span></li><li><span style=\"font-size:12.0pt;\">The elevated lymphocyte and neutrophil counts could be a secondary response but are not specific to thalassemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalassemia is characterized by a reduction in the synthesis of globin chains (alpha or beta), leading to ineffective erythropoiesis and anemia. The microcytosis and hypochromia (low MCV and MCH) are hallmarks of this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Anemia of chronic disorder</strong>: Typically presents with normal to reduced MCV and low serum iron, but ferritin is usually raised, not within the normal range.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Iron-deficiency anemia</strong>: Would show low serum ferritin, low MCV, and low MCH, but the serum ferritin here is normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Sickle cell anemia</strong>: Would not typically present with low MCV and MCH, as sickle cells tend to be normocytic or macrocytic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125253.jpg\" alt=\"\" width=\"1000\" height=\"410\"></p>",
      "correct_choice_id": 40079,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}